Normal Secondary Hemostasis (Part 1)

Discuss the physiological role and process involved in the coagulation phase of hemostasis

The coagulation cascade, which ultimately leads to the formation of a stable fibrin clot.

• The cascade functions through the conversion of zymogens (inactive factors, listed as Factor #) into active enzymes (listed as Factor #a) via proteolysis. These active enzymes then catalyze the conversion of subsequent zymogens in the sequence. The coagulation factors perform three primary functions:

  • Serine Proteases: Most factors, including Thrombin and Factors VII, IX, X, XI, and XII, are serine proteases that selectively cleave peptide bonds at their active sites.

  • Co-factors: Factors V and VIII act as co-factors that significantly accelerate these enzymatic reactions.

  • Transglutaminase: Factor XIII acts as a transglutaminase, catalyzing the formation of covalent peptide bonds to stabilize the final fibrin structure

The culmination of these pathways is the Common Pathway, where Factor Xa, working within the prothrombinase complex (alongside Factor Va, calcium, and phospholipids), converts prothrombin (Factor II) into thrombin. Thrombin is the central enzyme of the cascade and performs several critical roles:

• Fibrin Formation: Thrombin cleaves fibrinogen (Factor I) into fibrin monomers, which then polymerize to form the initial clot.

• Stabilization: Thrombin activates Factor XIII, which subsequently creates covalent bonds between fibrin chains to form a stable, insoluble clot.

• Feedback Loops: Thrombin provides positive feedback by activating Factors V, VIII, and XI, further accelerating the cascade

For these reactions to occur efficiently, several non-enzymatic components must be present:

• Calcium (Factor IV): Calcium is a necessary cofactor for many reactions, including the binding of factors to phospholipid surfaces and the activation of Factor XIII.

• Vitamin K: This fat-soluble vitamin is essential for the carboxylation of glutamic acid in Factors II, VII, IX, and X. This chemical modification allows these factors to bind to calcium and adhere to negatively charged phospholipid membranes, which is critical for their activation.

• Phospholipids: Provided by the membranes of activated platelets, these surfaces act as a template where various factors can aggregate and react

List and describe the three major functions of coagulation factors

1. Enzymes

The majority of coagulation factors function as enzymes, which are responsible for activating other factors through proteolysis:

• Serine Proteases: This group includes Thrombin and Factors VII, IX, X, XI, and XII. They all possess a functional serine at their active site and work by selectively cleaving arginine or lysine peptide bonds in other zymogens (inactive factors) to convert them into active enzymes.

• Transglutaminase: Factor XIII is the only factor with this specific enzymatic function. It catalyzes the formation of covalent peptide bonds between glutamine and lysine residues within fibrin, which stabilizes the initial fibrin clot.

2. Co-factors

Factors V and VIII are the primary co-factors in the coagulation cascade. Their essential role is to significantly accelerate the rate of the enzymatic reactions. For example, Factor V acts as a co-factor for Factor Xa, and Factor VIII works within the intrinsic pathway. Tissue Factor (Factor III) also serves as a necessary co-factor specifically for Factor VII.

3. Terminal Substrate

Fibrinogen (Factor I) is the terminal substrate of the entire coagulation cascade. Unlike the enzymes and co-factors, which facilitate the process, fibrinogen is the actual protein that is converted into the structural component of a blood clot. Thrombin cleaves fibrinogen into fibrin monomers, which then polymerize to form the stable, insoluble fibrin clot

Describe the prothrombin, fibrinogen, and contact factor groups

Prothrombin Group

This group consists of Factors II (prothrombin), VII, IX, and X, as well as regulatory proteins Protein C, Protein S, and Protein Z.

• Vitamin K Dependency: These factors are synthesized in the liver and are strictly Vitamin K dependent for their production. Vitamin K is required for the carboxylation of glutamic acid, a chemical modification that allows these factors to bind to calcium (Ca++).

• Mechanism: Once carboxylated, these factors use calcium "bridges" to bind to negatively charged phospholipid surfaces, which is a critical step for their activation.

• Physical Properties: They are relatively small proteins (molecular weight 50,000–100,000) and are characterized as being heat stable.

2. Fibrinogen Group

The fibrinogen group includes Factors I (fibrinogen), V, VIII, and XIII.

• Common Substrate: All members of this group serve as substrates for thrombin during the coagulation process.

• Consumption: Unlike enzymes that can be reused, these factors are consumed during the clotting process and are therefore absent from serum.

• Synthesis and Structure: These are large molecules (molecular weight approx. 250,000) synthesized in the liver. A notable exception is Factor VIII:vWF, which is produced by megakaryocytes and endothelial cells.

3. Contact Group

The contact group includes Factors XI and XII, along with Prekallikrein (PK) and High Molecular Weight Kininogen (HK/HMWK).

• Activation: These factors are activated when they come into contact with a negatively charged surface. In vivo, this surface is typically collagen; in vitro, activation can be triggered by substances like glass or kaolin.

• Presence in Serum: Members of this group are not consumed during coagulation and can be found in serum.

• Physiological Role: Their primary purpose is to activate the intrinsic pathway and the fibrinolytic system. While essential for laboratory testing, the activation of Factor XII is not believed to contribute significantly to normal clot formation in vivo, as patients deficient in this factor typically do not experience bleeding

List the Vitamin K dependent factors

The factors that are Vitamin K dependent are primarily members of the Prothrombin Group. These include:

• Factor II (Prothrombin)

• Factor VII

• Factor IX

• Factor X

• Protein C

• Protein S

• Protein Z

These factors are synthesized in the liver and require Vitamin K for the carboxylation of glutamic acid

Describe the role of Vitamin K in coagulation factor synthesis

Vitamin K is essential for the synthesis of functional coagulation factors within the Prothrombin Group, which includes Factors II (prothrombin), VII, IX, and X, as well as regulatory proteins Protein C, Protein S, and Protein Z. These factors are synthesized in the liver and require a specific chemical modification to become active.

The specific role of Vitamin K and the resulting processes include:

• Carboxylation of Glutamic Acid: Vitamin K serves as a necessary cofactor for the enzyme carboxylase, which adds a carboxyl group to glutamic acid residues on these specific proteins.

• Calcium Binding: This carboxylation modification is critical because it creates a domain on the factors that allows them to bind to calcium (Ca++).

• Phospholipid Membrane Adherence: Once bound to calcium, these factors can form "bridges" to adhere to negatively charged phospholipid surfaces. This localization to the membrane surface is a requirement for the factors to participate effectively in the enzymatic reactions of the coagulation cascade.

• Consequences of Deficiency: In the absence of Vitamin K, the liver produces these factors, but they remain non-functional because they cannot bind to calcium or phospholipid membranes. This process is the target of the anticoagulant drug Warfarin, which inhibits the recycling of Vitamin K by blocking the enzyme epoxide reductase

List and describe the coagulation factors by roman numeral, common name designation, and major function(s)

• Factor I (Fibrinogen): Acts as the terminal substrate and precursor to fibrin. It is cleaved by thrombin into fibrin monomers that polymerize to form the structural basis of a blood clot.

• Factor II (Prothrombin): A serine protease and the precursor to thrombin. It has multiple roles: it converts fibrinogen to fibrin, activates Factors V, VIII, and XI, and acts as an anticoagulant by activating Protein C. It also plays roles in inflammation and cellular proliferation.

• Factor III (Tissue Factor): A necessary co-factor for the activation of Factor VII and a constituent of the extrinsic Xase complex.

• Factor IV (Calcium): An element that serves as a vital cofactor in several coagulation reactions, specifically enabling various factors to bind to phospholipid surfaces via calcium "bridges".

• Factor V (Proaccelerin or Labile Factor): A co-factor that significantly accelerates the reaction rate of the prothrombinase complex (working with Factor Xa).

• Factor VI: This designation is not used.

• Factor VII (Proconvertin or Stable Factor): A serine protease and a constituent of the extrinsic Xase complex.

• Factor VIII (Antihemophilic Factor): A co-factor in the intrinsic Xase complex. It circulates as a complex with von Willebrand factor (vWF). Transcribed from a gene on the X chromosome.

• Factor IX (Christmas Factor or Plasma Thromboplastin Component): A serine protease and a constituent of the intrinsic Xase complex.

• Factor X (Stuart Factor or Stuart-Prower Factor): A serine protease and the primary constituent of the prothrombinase complex.

• Factor XI (Plasma Thromboplastin Antecedent): A serine protease and member of the contact group.

• Factor XII (Hageman Factor): A serine protease and contact factor that works with other factors to activate Factor XI. Bleeding does not occur in its absence.

• Factor XIII (Fibrin-Stabilizing Factor): A transglutaminase that catalyzes the formation of covalent peptide bonds between fibrin chains, stabilizing the initial clot.

• HK (High Molecular Weight Kininogen or Fitzgerald Factor): A co-factor and contact factor complexed with PK and Factor XI.

• PK (Prekallikrein or Fletcher Factor): A serine protease and contact factor complexed with HK.

• vWF (von Willebrand Factor): Responsible for platelet adhesion and the stabilization of circulating Factor VII

State the location of the gene responsible for Factor VIII

The gene responsible for Factor VIII (antihemophilia factor), known by the gene symbol F8, is located on the X chromosome,. Specifically, its chromosomal location is Xq28

Diagram/label the Fibrinogen molecule

The fibrinogen molecule (Factor I) is a large, trinodular glycoprotein with a molecular weight of approximately 340 kDa. Its structure is composed of six polypeptide chains (two sets of three different chains) that are held together by disulfide bonds.

Structural Components and Regions

Based on the provided structural diagrams, the molecule is organized into the following regions:

• E Nodule: The central globular domain of the molecule. This region contains the N-terminals of all six polypeptide chains.

• D Nodules: Two distal globular domains located at opposite ends of the molecule.

• Supercoiled Region: The elongated, rod-like sections that connect the central E nodule to the two outer D nodules.

The Six Polypeptide Chains

The molecule consists of three pairs of chains:

• Aα Chains (2): These chains contain the A peptides at their ends, which are located near the E nodule.

• Bβ Chains (2): These chains contain the B peptides at their ends, also protruding near the central region.

• γ Chains (2): These chains complete the hexameric structure and extend from the E nodule to the D nodules

Outline the in vivo (cell-based) coagulation cascade in the correct order

Initiation and Injury

• Vascular Damage: Injury to the vessel wall damages the endothelium and exposes the subendothelial basement membrane.

• Platelet Adhesion: Platelets adhere to exposed collagen in the subendothelium and become activated, releasing further procoagulant agents.

• Tissue Factor Exposure: Tissue damage releases Tissue Factor (TF), also known as Factor III.

2. The Extrinsic Xase Complex

• Formation: Factor VII binds to the exposed Tissue Factor (TF) on the cell surface to form the Extrinsic Xase complex.

• Activation: This complex, in the presence of calcium (Ca++), activates small amounts of Factor X into Factor Xa and Factor IX into Factor IXa.

3. The Intrinsic Xase Complex (Amplification)

• Formation: Factor IXa (generated by the extrinsic complex) moves to the phospholipid (PL) surface of activated platelets. It combines with its co-factor Factor VIIIa and calcium to form the Intrinsic Xase complex.

• Role: This complex is significantly more efficient at activating Factor X into Factor Xa than the extrinsic complex alone.

4. The Prothrombinase Complex

• Formation: Factor Xa combines with its co-factor Factor Va and calcium on the platelet phospholipid membrane to form the Prothrombinase complex.

• Thrombin Generation: This complex converts Prothrombin (Factor II) into the central enzyme Thrombin (Factor IIa).

5. Fibrin Formation and Stabilization

• Fibrin Production: Thrombin cleaves the terminal substrate Fibrinogen (Factor I) into fibrin monomers, which polymerize to form fibrin polymers.

• Stabilization: Thrombin also activates Factor XIII into Factor XIIIa.

• The Stable Clot: Factor XIIIa catalyzes the formation of covalent peptide bonds between the fibrin chains, turning the initial weak polymer into a stable, insoluble fibrin clot

Compare and contrast the extrinsic and intrinsic Xase complexes

The primary differences lie in their specific molecular components and their roles within the in vivo (cell-based) model of coagulation:

Feature	Extrinsic Xase Complex	Intrinsic Xase Complex
Active Enzyme	Factor VIIa	Factor IXa
Cofactor	Tissue Factor (Factor III)	Factor VIIIa
Location	Forms on the surface of cells where Tissue Factor is exposed due to injury.	Forms on the phospholipid (PL) surface of activated platelets.
Substrates	Activates both Factor X and Factor IX.	Specifically activates Factor X.
Efficiency	Acts as the initiator of the cascade, producing the initial small amounts of Xa and IXa.	Acts as a powerful amplifier; it is significantly more efficient at activating Factor X than the extrinsic complex

Describe the importance of phospholipid surfaces to secondary hemostasis

Phospholipid surfaces, primarily provided by activated platelets, are essential to secondary hemostasis because they serve as the physical template for the assembly and optimal functioning of the coagulation factor complexes.

The importance of these surfaces can be described through the following key roles:

1. Binding Site for Vitamin K-Dependent Factors

Coagulation factors in the Prothrombin Group (Factors II, VII, IX, and X) are physically unable to participate in the cascade unless they can adhere to a membrane.

• Calcium Bridges: These factors contain a specific domain that, following Vitamin K-dependent carboxylation, allows them to bind to calcium (Ca++).

• Membrane Adherence: The calcium then acts as a "bridge," linking the protein to the negatively charged phospholipid surfaces on the cell membrane. Without this phospholipid-calcium link, these factors remain non-functional.

2. Template for Complex Assembly

The major enzymatic reactions of the coagulation cascade do not occur in isolation but within multi-component complexes that must be localized on a phospholipid (PL) surface. These include:

• Intrinsic Xase Complex: Composed of Factors IXa, VIIIa, and calcium, this complex assembles on the PL surface to activate Factor X.

• Prothrombinase Complex: Composed of Factors Xa, Va, and calcium, this complex assembles on the PL surface to convert prothrombin into thrombin.

• Protein C Complex: Regulatory proteins also use these surfaces to activate Protein C, which then provides anticoagulant feedback.

3. Dramatic Increase in Reaction Efficiency

By concentrating the necessary enzymes, co-factors, and substrates in one localized area on the phospholipid membrane, the rate of chemical reactions is significantly accelerated. For example, the prothrombinase complex is vastly more efficient at generating the "thrombin burst" when it is assembled on the platelet phospholipid surface than if the factors were moving freely in the plasma.

4. Localization of the Clot

The requirement for a phospholipid surface ensures that the coagulation process is localized to the site of injury where activated platelets have gathered. This prevents the dangerous, widespread formation of fibrin throughout the entire circulatory system by restricting the most powerful enzymatic reactions to the surface of the growing platelet plug